OBJECTIVE: The characteristics of sleep apnoea syndrome (SAS) in the elderly, including subtype classification and association with mortality, have not been fully elucidated. This study examined these factors in an elderly Japanese inpatient population. METHODS: Overnight polysomnography was used to diagnose and classify SAS in 145 elderly inpatients (mean ± age 81 ± 8 years). Clinical data, including brain computerized tomography findings, were recorded. The study population included nine inpatients with obstructive SAS, 12 with central SAS, 25 with mixed SAS and 99 controls (no SAS). RESULTS: Increased body mass index and grade of aortic arch calcification independently contributed to risk of all subtypes of SAS combined. There was an independent association between SAS and increased risk of mortality from all causes as well as from pneumonia and from cardiovascular disease.
Introduction
Sleep apnoea syndrome (SAS) is estimated to affect 2 -4% of middle-aged adults in the USA, 1 with a higher prevalence (7.5%) reported in Japanese industrial workers. 2 Obstructive SAS, the predominant subtype in middle-aged populations, is an independent risk factor for hypertension 3 and stroke, 4 and is associated with increased cardiovascular disease mortality. 5 Central SAS is often accompanied by congestive heart failure and is associated with increased mortality. 6 The clinical characteristics and mortality risks of other subtypes of SAS, such as mixed SAS, 7 have not, however, been studied.
Studies indicate a relatively high prevalence of SAS in the elderly, 8, 9 and increased SAS-related mortality was reported S Morimoto, T Takahashi, K Okaishi et al. Sleep apnoea syndrome and mortality in the elderly in a cohort of noninstitutionalized elderly individuals. 10 Detailed characteristics of SAS in the elderly, including subtype classification, clinical contributing factors for each subtype, and association with mortality (especially pneumonia and cardiovascular disease which are two major causes of death in disabled elderly subjects 11 ) have not been fully elucidated. The present study examined these factors in an elderly inpatient population.
Patients and methods

STUDY POPULATION
This study was conducted at Sengi Hospital, Kanazawa, Japan -a 540-bed hospital and long-term care facility for elderly persons, which is a common combination in Japan of medical and care services. 12 Consecutive Japanese inpatients aged ≥ 65 years with an admission period of at least 6 months and who were hospital inpatients at the time of the study were enrolled. Exclusion criteria were: (i) immunocompromised state; (ii) hypothyroidism; (iii) receiving oxygen administration; (iv) pneumonia within the past 3 months; and (v) renal failure (serum creatinine > 265 µmol/l).
The research protocol was approved by the Ethics Committee of Sengi Hospital. All in patients who gave written informed consent (or whose family members gave consent) were enrolled. 13 coronary artery disease, 13 deterioration of congestive heart failure, pneumonia and other causes were collected daily. Pneumonia was not listed as a cause of death in patients with pneumonia who died during the acute or critical phase of any of the other listed illnesses; rather, the cause of death was determined to be the underlying disease. None of the inpatients received treatment for SAS.
OBSERVATION OF PATIENTS
Known contributing factors for SAS were recorded. These included: body mass index (BMI); 14 serum levels of albumin and total cholesterol; hypertension (systolic and/or diastolic blood pressure ≥ 140/90 mmHg, or drug treatment); 3 chronic cardiovascular disease (previous myocardial infarction or angina pectoris); 4 chronic heart failure (left ventricular ejection fraction < 40%); chronic phase of stroke (motor deficit and evidence of cerebral deficit on computerized tomography [CT]); 15 diabetes mellitus (fasting blood glucose ≥ 7 mmol/l, or drug treatment); dementia (Mini-Mental State Examination score ≤ 23); 16 past history of lung disease (chronic bronchitis, emphysema, bronchiectasis, interstitial lung disease or sequelae of tuberculosis); atrial fibrillation; and bedridden state. Severity of aortic arch calcification (AAC) on the chest X-ray was graded as previously determined: 17 grade 0, no visible calcification; grade 1, small spots of calcification or single thin calcification of the aortic bulb; grade 2, one or more areas of thick calcification; and grade 3, circumferential calcification of the aortic bulb. Data were retrieved from medical records before the start of the examination (i.e. before SAS screening and brain CT). Personal physicians made the diagnoses, which were further evaluated by a committee of expert physicians convened for the purposes of this study. Routinely collected medical information (patients' previous history of illnesses, current complications, S Morimoto, T Takahashi, K Okaishi et al. Sleep apnoea syndrome and mortality in the elderly current medications, and the family histories of illnesses) was used to improve diagnostic accuracy.
DIAGNOSIS AND CLASSIFICATION OF SAS
Screening for SAS was performed using a pulse oximeter (Pulsox-24M; Teijin, Osaka, Japan) according to the method by Raymond et al. 18 Oximetric arterial oxygen saturation (SaO 2 ) was assessed from 21.00 h to 07.00 h whilst patients were in bed. Pulse oximetry was measured 12 times per minute, with each data point representing the lowest saturation level in a 5-s interval. Inpatients with at least five desaturation events per hour (defined as a ≥ 3% decrease in SaO 2 ) were selected as candidates for SAS. All patients underwent overnight polysomnography with a cardiorespiratory monitoring device (Morpheus ® ; Teijin) to diagnose and classify SAS types. 19 Apnoea was defined as complete cessation of airflow for ≥ 10 s, and hypopnoea as a ≥ 50% reduction in oronasal airflow for ≥ 10 s or a decrease in SaO 2 of ≥ 3% for ≥ 10 s. The apnoea-hypopnoea index (AHI) was defined as the frequency of these events per hour during overnight recording. 19 SAS severity was classified as mild (AHI 5 -< 15 events/h), moderate (AHI 15 -< 30 events/h), or severe (AHI ≥ 30 events/h). 7 Apnoea events were classified as obstructive, central, or mixed SAS. 7 Obstructive SAS was defined as the need for thoracic effort for continued breathing following complete cessation of air flow. Central SAS was characterized as the complete cessation of both the respiratory system and air flow for ≥ 10 s. Mixed SAS was a mix of obstructive SAS and central SAS, defined as a pause of the respiratory system followed by obstruction of ventilation for a relatively short term.
BRAIN CT EXAMINATION
The CT images of the brain were obtained along the orbitomental line of a 0.5 cm thick slice using X-Force apparatus (Toshiba Electric Co., Tokyo, Japan). Leukoaraiosis (i.e. nonspecific changes in the cerebral white matter that can be detected with high frequency by CT and magnetic resonance imaging in aged individuals) was assessed in seven brain regions and recorded as: absent, 0; mild, 1; or severe, 2. 20 Mean scores across the seven regions were calculated. The presence (1) or absence (0) of lacunar infarctions in the basal ganglia, as well as cortical deficit due to previous cerebral haemorrhage or infarction, were noted. 21
STATISTICAL ANALYSES
Data were analysed using SPSS ® software package version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Data were expressed as mean ± SD for continuous variables and number (percentage) for categorical variables. Comparisons between two groups for association between SAS and clinical variables were examined by the χ 2 -test for categorical variables and the Mann-Whitney U-test for continuous variables. Comparisons among three or more groups were analysed by the Kruskal-Wallis test and Mann-Whitney U-test with post hoc Bonferroni correction. Multiple logistic regression analysis was carried out to determine independent contributing factors for SAS using the confounding factors of age, male gender and potential factors (e.g. congestive heart failure) at P < 0.20. 22 Conditional multiple logistic regression analysis was performed to determine independently contributing factors between the control group and obstructive, central or mixed SAS.
Patients with no fatal events were censored at the end of the study period and S Morimoto, T Takahashi, K Okaishi et al. Sleep apnoea syndrome and mortality in the elderly excluded from the analysis. Cumulative risks of fatal events in the control group and SAS subtypes were plotted using the life table method (Kaplan-Meier analyses). Unadjusted odds ratios (OR) and 95% confidence intervals (95% CI) of fatal events, according to age, gender and SAS risk factors, were estimated by the Cox proportional hazards model. Multivariate models were used to adjust for potential confounding factors at P < 0.20. 22 Cases of death due to underlying disease were not included in analysis of death from pneumonia or cardiovascular disease. A twotailed value of P < 0.05 was considered to be statistically significant.
Results
The study recruited 151 elderly inpatients. Six patients (4%) who had no follow-up data because of discharge from hospital were excluded and so the final study population included 145 inpatients (38 males/107 females; mean ± SD age 81 ± 8 years; age range 66 -96 years). The study population comprised 46 (32%) patients with SAS; nine (6%) with obstructive SAS; 12 (8%) with central SAS and 25 (17%) with mixed SAS.
Demographic and clinical data for the study population are given in Table 1 . The prevalence of congestive heart failure was significantly higher in patients with central SAS than in controls (no SAS) (P = 0.006). Patients with SAS had a higher BMI than controls, but this did not reach statistical significance.
Obstructive SAS was characterized by a significantly lower mean grade of leukoaraiosis compared with central SAS and mixed SAS (P = 0.001 for both), and a significantly lower prevalence of lacunar infarction than controls and central SAS (P < 0.001 for both). The aortic arch calcification (AAC) grade was significantly higher in patients with obstructive or central SAS patients than in controls (P < 0.001 for both). There were no significant differences between the three SAS subtypes in SAS severity or AHI.
Multiple logistic regression analysis revealed that higher AAC grade ( During 341 person-years of follow-up, 55 (38%) patients died. The incidence of fatal events was 12.6/100 person-years. Causes of death are given in Table 2 . These 55 patients were followed-up for a mean ± SD of 15.4 ± 9.9 months (range 1 -35 months). Overall mortality rate was significantly higher in patients with SAS than in controls (P = 0.006) and significantly more SAS patients than controls died of pneumonia (P = 0.049) or cardiovascular disease (P < 0.001).
Kaplan-Meier analyses of cumulative rates of mortality are shown in Fig. 1 . Cox proportional hazards model analysis (using controls and each subtype of SAS as a categorical group) revealed that only mixed SAS was independently and positively associated with mortality from pneumonia (P = 0.011). Obstructive, central and mixed SAS were all significantly and positively associated with all-cause mortality (P = 0.004, P = 0.004 and P = 0.005, respectively) and mortality from cardiovascular disease (P < 0.001, P < 0.001 and P = 0.037, 
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Discussion
The prevalence of SAS in the elderly inpatients in the present study was 32%, 
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which is much higher than that reported in Japanese industrial workers, 2 but consistent with other reports. 8, 9 The present study revealed a predominance of mixed and central SAS among elderly SAS inpatients, in contrast to previous reports in young and middle-aged subjects 3 and in the elderly 9 in which obstructive SAS was the predominant subtype. This difference may be due to the fact that almost all the subjects in the present study were disabled elderly inpatients.
Multiple logistic regression analysis revealed that factors known to be related to SAS in younger subjects 3, 23 were not associated with SAS in the elderly, although higher BMI 14 was found to be associated with SAS. The present study revealed that AAC, a known risk for coronary heart disease and ischaemic stroke, 24 was an independent risk factor for obstructive and central SAS in elderly inpatients. The patients with obstructive SAS in the present study were relatively free from ischaemic impairment of the brain, such as lacunae and leukoaraiosis, compared with controls and other SAS subtypes. A higher grade of leukoaraiosis was independently related to the risk of mixed SAS in this population. These observations are in contrast to the findings of Davies et al., 25 who reported no significant difference in the prevalence of either lacunae or leukoaraiosis between obstructive SAS patients and controls aged 30 -80 years. Mixed SAS is thought to develop in patients with obstructive SAS who also experience episodes of apparent central SAS. 7 Mild hypoxaemia and/or mild hypocapnia due to hypoxaemia induced hyperventilation have been reported to contribute to the shift from obstructive to mixed SAS. 26 In addition, central SAS can be secondary to damage to the respiratory centre of the brain, as seen in cases of ischaemic brain stem infarction. 7 These observations suggest that age-related ischaemic brain damage represented by lacunae and/or leukoaraiosis may result in a decrease in the prevalence of obstructive SAS and instead a predominance of mixed and/or central SAS.
The main cause of death in the present study was pneumonia followed by cardiovascular disease, a finding that is partly in accordance with reports from a disabled elderly population, 11 and elderly patients with SAS. 27 The present study showed SAS to be an independent predictor of reduced survival due to all-cause mortality and also mortality due to pneumonia and cardiovascular disease. In addition, an independent association between mixed SAS and increased mortality due to pneumonia was found. The precise mechanism of this association is not clear but severe leukoaraiosis predicted pneumonia death (with a hazard ratio of 8.3) in a study of patients with neurological deficit. 28 Since leukoaraiosis was associated with increased risk of mixed SAS in the present study, the relationship between mixed SAS and pneumonia mortality may be mediated by leukoaraiosis.
Obstructive, central and mixed SAS were all independent risk factors for both all-cause mortality and mortality from cardiovascular disease. Obstructive SAS increases mortality from cardiovascular disease in the general population 5, 6 and in the elderly. 29 Central SAS has also been associated with increased mortality from cardiovascular disease in the general population 30 and in an elderly population. 31 The present study also revealed an independent contribution of mixed SAS to mortality from cardiovascular disease, in addition to death from pneumonia.
Neither AHI nor SAS severity were associated with any cause of death in the • Received for publication 3 April 2011 • Accepted subject to revision 10 August 2011
• Revised accepted 14 March 2012 Copyright © 2012 Field House Publishing LLP present study. Previous studies have found a significant association between severity of obstructive SAS and coronary artery disease, 32 and severity of central SAS and congestive heart failure mortality. 31 Lavie et al. 33 found that the association between SAS severity and increased mortality disappeared in older SAS patients. The high mean age of the patients in the present study may be one of the causes of the lack of association between SAS severity and mortality of any cause.
In conclusion, the present study found an increased risk of cardiovascular and allcause mortality in elderly inpatients with obstructive, central and mixed SAS. Mixed SAS was associated with an increase in mortality from pneumonia. There was no relationship between mortality and severity of SAS. Future trials should be conducted to determine a definite relationship between SAS and mortality using a larger number of patients.
